US Broker Ratings

Merck & Company, Inc. (MRK) Stock Analysis: Key Insights on its 4.27% Upside Potential

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, continues to attract investor attention with its robust market presence and promising growth prospects. With a market capitalization..

Becton, Dickinson and Company (BDX) Stock Analysis: Navigating Healthcare Growth with a Diverse Product Portfolio

Investors with a keen eye on the healthcare sector will undoubtedly recognize Becton, Dickinson and Company (NYSE: BDX) as a stalwart in medical instruments and supplies. With a robust market..

Alnylam Pharmaceuticals (ALNY): Growth Potential Highlighted by Robust Pipeline and 36.85% Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, is garnering significant attention from investors due to its innovative approach in developing therapeutics based on ribonucleic acid interference..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring a $109.81 Billion Market Giant with a 3.92% Potential Upside

HCA Healthcare, Inc. (HCA), a formidable entity in the healthcare sector, operates an expansive network of hospitals and healthcare facilities across the United States. With a market capitalization of $109.81..

IDEXX Laboratories, Inc. (IDXX)

⚠️ No article content returned.

..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 16.20% Potential Upside in the Healthcare Sector

Alcon Inc. (ALC), a stalwart in the healthcare sector, specifically within the medical instruments and supplies industry, presents a compelling prospect for investors with its innovative eye care solutions. Headquartered..

McKesson Corporation (MCK) Stock Analysis: A Healthcare Giant with 12% Upside Potential

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, stands out as a robust investment opportunity with a market capitalization of $104.54 billion. This Texas-based company specializes in medical..

Cardinal Health, Inc. (CAH) Stock Analysis: Navigating the Healthcare Giant’s 6.82% Potential Upside

Cardinal Health, Inc. (NYSE: CAH) stands out as a major player in the healthcare sector, specifically within the medical distribution industry. With a market capitalization of $50.48 billion, the company..

AstraZeneca PLC (AZN) Stock Analysis: Riding a Revenue Growth Wave with a 4.8% Upside Potential

AstraZeneca PLC (NASDAQ: AZN), a leading player in the global healthcare sector, is currently capturing investor attention with its impressive market cap of $292.78 billion and a robust revenue growth..

Takeda Pharmaceutical Company L (TAK) Investor Outlook: Navigating a 9.69% Upside Potential

Takeda Pharmaceutical Company Limited (NYSE: TAK), a giant in the healthcare sector, offers a tantalizing prospect for investors with its 9.69% potential upside. As Japan’s leading drug manufacturer specializing in..

CVS Health Corporation (CVS) Stock Analysis: Exploring a 20.81% Potential Upside Amid Strong Analyst Ratings

CVS Health Corporation (NYSE: CVS), a leading player in the healthcare plans industry, stands at a pivotal juncture with a market capitalization of $99.78 billion. The company’s recent stock performance,..

Boston Scientific Corporation (BSX) Stock Analysis: An Attractive 41% Potential Upside Beckons Investors

Boston Scientific Corporation (NYSE: BSX), a significant player in the healthcare sector, has long been a cornerstone in the medical devices industry. With a market capitalization of $130.61 billion, this..

Regeneron Pharmaceuticals (REGN) Stock Analysis: A Biotech Powerhouse with 12.69% Upside Potential

Regeneron Pharmaceuticals, Inc. (REGN), a leading name in the biotechnology sector, continues to capture investor attention with its robust pipeline and strong market presence. Headquartered in Tarrytown, New York, Regeneron..

Amgen Inc. (AMGN) Stock Analysis: Robust Revenue Growth and Strategic Partnerships Propel Investor Interest

Amgen Inc. (AMGN), a titan in the healthcare sector, continues to capture investor attention with its impressive revenue growth and strategic collaborations. As a leading player in the drug manufacturing..

Bristol-Myers Squibb (BMY) Stock Analysis: Navigating Growth with a Solid Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY) stands as a formidable presence in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of $112.5 billion, it is a..

Johnson & Johnson (JNJ) Investor Outlook: Navigating a Solid Healthcare Giant with a Robust 33.62% Return on Equity

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to command attention with its formidable market cap of $526.82 billion. Based in New Brunswick, New Jersey, and..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Exploring a 23% Upside Potential and Robust Free Cash Flow

Emergent BioSolutions Inc. (NYSE: EBS) stands as a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Gaithersburg, Maryland, this life sciences..

Personalis, Inc. (PSNL) Stock Analysis: A Promising 14.46% Upside Potential Amid Strategic Collaboration

Personalis, Inc. (NASDAQ: PSNL), a prominent player in the healthcare sector, specializes in diagnostics and research with a focus on advanced cancer genomic tests. As the company stands at a..

Treace Medical Concepts, Inc. (TMCI): Investor Outlook Highlights 83.77% Potential Upside

Investors with an interest in the healthcare sector, particularly in medical devices, should keep a keen eye on Treace Medical Concepts, Inc. (NASDAQ: TMCI). This Florida-based company, with a market..

EyePoint, Inc. (EYPT) Stock Analysis: Exploring the 127.80% Potential Upside in a Challenging Market

Investors with a keen interest in the biotechnology sector might find EyePoint, Inc. (EYPT) an intriguing prospect, particularly given its staggering potential upside of 127.80%. As a player in the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds